# Vaccination of High Risk Breast Cancer Patients

> **NCT01390064** · PHASE1 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 6 (actual)

## Conditions studied

- Stage IV Breast Cancer

## Interventions

- **BIOLOGICAL:** Vaccination with Mimotope P10s-PADRE/MONTANIDE ISA 51 VG

## Key facts

- **NCT ID:** NCT01390064
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2018-07
- **Final completion:** 2019-07
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390064, "Vaccination of High Risk Breast Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01390064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*